-
1
المؤلفون: Yongping Song, Ting Liu, Donglu Zhao, Xiaobing Huang, Wei Xu, Guangxun Gao, Haiyan Yang, Jun Zhu, Jinghua Wang, Wei-Li Zhao, Qingqing Cai, Min Mao, Zhihui Zhang, Qingshu Zeng, Hongwei Xue, Kaiyang Ding, Jingyan Xu, Hang Su, Yuankai Shi, Ting Niu, Liling Zhang, Peng Liu, Hongyu Zhang, Jianzhen Shen, Lihong Liu, Huiqiang Huang, Jianfeng Zhou, Xiaojing Yan, Ru Feng, Jie Jin, Jianda Hu, Huilai Zhang, Xin Wang, Jun Ma, Huo Tan, Lugui Qiu, Bing Xu, Yu Yang, Daobin Zhou, Hui Zhou, Zhi-Xiang Shen, Ou Bai, Weiping Liu, Wenyu Li, Zhi Ming Li, Ming Hou
المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)مصطلحات موضوعية: safety, Oncology, medicine.medical_specialty, Cancer Research, medicine.medical_treatment, T cell, lymphoma, histone deacetylase inhibitors, survival, chemistry.chemical_compound, T-cell, Refractory, Chidamide, Internal medicine, medicine, peripheral, Adverse effect, Objective response, RC254-282, Original Research, Chemotherapy, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Peripheral, Lymphoma, medicine.anatomical_structure, chemistry, efficiency, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58fe4731b3498f051335b4853ed8a940Test
-
2
المؤلفون: Yan Li, Yiqi Ma, Zijun Wu, Fanxin Zeng, Bin Song, Yanrong Zhang, Jinxing Li, Su Lui, Min Wu
المصدر: Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunologyمصطلحات موضوعية: Oncology, medicine.medical_specialty, Colorectal cancer, business.industry, overall survival, Hazard ratio, Immunology, Cancer, Microsatellite instability, colorectal cancer, Odds ratio, Publication bias, RC581-607, tumor mutation burden, medicine.disease, immune checkpoint inhibitors, Internal medicine, Meta-analysis, medicine, Biomarker (medicine), Immunology and Allergy, Systematic Review, Immunologic diseases. Allergy, business, objective response rate
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ac0fe2197882c3e2787f50511e57decTest
-
3
المؤلفون: Jiting Wang, Song Su, Jun Li, Yaling Li
المصدر: Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncologyمصطلحات موضوعية: 0301 basic medicine, Oncology, safety, medicine.medical_specialty, Cancer Research, Combination therapy, medicine.medical_treatment, Combined use, efficacy, combination therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Clinical endpoint, Medicine, Adverse effect, Objective response, RC254-282, Chemotherapy, camrelizumab, business.industry, Rate control, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, meta-analysis, 030104 developmental biology, 030220 oncology & carcinogenesis, Meta-analysis, monotherapy, Systematic Review, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9432a16ced01940c783e88d78ab8fd8Test
-
4
المؤلفون: Wei Mao, Can Hu, Ping Hu, Guofa Yu, Yu Zhang, Shanqi Chen, Xiang-Dong Cheng, Conggang Hu, Zhiyuan Xu, Jianfa Yu, Yian Du
المصدر: Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacologyمصطلحات موضوعية: safety, 0301 basic medicine, medicine.medical_specialty, medicine.medical_treatment, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, medicine, Pharmacology (medical), Apatinib, Objective response, Original Research, Pharmacology, Chemotherapy, business.industry, gastric cancer, lcsh:RM1-950, Cancer, Advanced gastric cancer, medicine.disease, Surgery, lcsh:Therapeutics. Pharmacology, 030104 developmental biology, Paclitaxel, chemistry, conversion surgery, Anastomotic leakage, 030220 oncology & carcinogenesis, unresectable abdominal neoplasms, Gastrectomy, business, apatinib
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed58febf005095e315b56e7d9b9a771Test
https://doi.org/10.3389/fphar.2021.642511Test -
5
المؤلفون: Jindi Han, Jian Fang, Ziran Zhang, Jie Zhang, Jun Nie, Sen Han, Xiangjuan Ma, Yang Wang, Di Wu, Weiheng Hu, Jieran Long, Xiaoling Chen, Guangming Tian, Ling Dai
المصدر: Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncologyمصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, survival, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Immune system, Internal medicine, PD-L1, medicine, real-world evidence, Lung cancer, Adverse effect, non-small cell lung cancer, Original Research, biology, business.industry, Cancer, Retrospective cohort study, Immunotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, adverse events, objective response, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, immunotherapy, Non small cell, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d28bdde7d0a4e760545ea2ab3d9045dTest
https://doi.org/10.3389/fonc.2021.607531Test -
6
المؤلفون: Jin Kang, Xu-Chao Zhang, Hua-Jun Chen, Wen-Zhao Zhong, Yang Xu, Jian Su, Qing Zhou, Hai-Yan Tu, Zhen Wang, Chong-Rui Xu, Xue-Ning Yang, Zhi-Hong Chen, Xue Wu, Xian Zhang, Yang Shao, Yi-Long Wu, Jin-Ji Yang
المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)مصطلحات موضوعية: Cancer Research, complex ALK fusions, Crizotinib, business.industry, Treatment outcome, EML4-ALK, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Oncology, hemic and lymphatic diseases, non-canonical ALK fusion, tyrosine kinase inhibitors, medicine, Cancer research, Anaplastic lymphoma kinase, In patient, Non small cell, Lung cancer, business, Tyrosine kinase, Objective response, non-small cell lung cancer, medicine.drug, Original Research
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49c5a22ac5f9336e6f39a6b3378f8a64Test
-
7
المؤلفون: Pil Soo Sung, Moon Hyung Choi, Hyun Yang, Soon Kyu Lee, Ho Jong Chun, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Joon-Il Choi, Young Joon Lee, Si Hyun Bae
المصدر: Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncologyمصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Urology, hepatic arterial infusion chemotherapy, lcsh:RC254-282, magnetic resonance, 03 medical and health sciences, 0302 clinical medicine, medicine, Effective diffusion coefficient, diffusion restriction, Stage (cooking), Original Research, oncology_oncogenics, Cisplatin, medicine.diagnostic_test, business.industry, Magnetic resonance imaging, hepatocellular carcinoma, Odds ratio, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, BCLC Stage, body regions, objective response, Oncology, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, 030211 gastroenterology & hepatology, Liver cancer, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c6fb94e424387ca0ade630d7b8ef10Test
https://doi.org/10.3389/fonc.2020.600233Test -
8
المؤلفون: Yi Yang, Gang Jin, Yao Pang, Yijie Huang, Wenhao Wang, Hongyi Zhang, Guangxin Tuo, Peng Wu, Zequan Wang, Zijiang Zhu
المصدر: Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacologyمصطلحات موضوعية: safety, 0301 basic medicine, Oncology, medicine.medical_specialty, Combination therapy, efficacy, Ipilimumab, Cochrane Library, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, advanced cancer, Pharmacology (medical), ipilimumab, Adverse effect, Objective response, nivolumab, Pharmacology, business.industry, lcsh:RM1-950, Advanced cancer, lcsh:Therapeutics. Pharmacology, 030104 developmental biology, 030220 oncology & carcinogenesis, Meta-analysis, combination immunotherapy, Systematic Review, Nivolumab, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe51e50ff2222d1e62abc24a131c22cTest
https://doi.org/10.3389/fphar.2020.00040Test -
9
المؤلفون: Jian Hu, Dajing Xia, Yihua Wu, Wang Lv, Chengli Du, Jinming Xu, Yongfeng Wu
المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Cancer Research, tumor mutational burden, overall survival, Subgroup analysis, tumor mutation burden, lcsh:RC254-282, immune checkpoint inhibitors, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Progression-free survival, Lung cancer, Exome sequencing, business.industry, Hazard ratio, Odds ratio, Publication bias, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, meta-analysis, 030104 developmental biology, 030220 oncology & carcinogenesis, Meta-analysis, Systematic Review, business, progression-free survival, objective response rate
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d31b6d5e2b62398eab1e7221110fa64dTest
-
10
المؤلفون: Gang Xue, Ze-Jia Cui, Xiong-Hui Zhou, Yue-Xing Zhu, Ying Chen, Feng-Ji Liang, Da-Nian Tang, Bing-Yang Huang, Hong-Yu Zhang, Zhi-Huang Hu, Xi-Yu Yuan, Jianghui Xiong
المصدر: Frontiers in Genetics
Frontiers in Genetics, Vol 10 (2019)مصطلحات موضوعية: 0301 basic medicine, lcsh:QH426-470, Lasso model, Genome, 03 medical and health sciences, 0302 clinical medicine, PD-L1, PD-1/PD-L1 inhibition therapy, Genetics, Medicine, KEGG, Gene, Genetics (clinical), Original Research, DNA methylation, biology, Receiver operating characteristic, business.industry, biomarkers, Blockade, lcsh:Genetics, 030104 developmental biology, CpG site, 030220 oncology & carcinogenesis, biology.protein, Cancer research, Molecular Medicine, business, objective response rate
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939d2d26b27291c8ad4970b9b04394e3Test